XML 19 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities    
Net income (loss) $ 174 $ (275)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Depreciation, depletion, and amortization 990 1,115
Deferred income taxes 42 (660)
Dry hole expense and impairments of unproved properties 106 1,012
Impairments 19 373
(Gains) losses on divestitures, net 24 (804)
Total (gains) losses on derivatives, net 36 (147)
Operating portion of net cash received (paid) in settlement of derivative instruments (63) (8)
Other 74 83
Changes in assets and liabilities    
(Increase) decrease in accounts receivable 23 68
Increase (decrease) in accounts payable and other current liabilities 45 395
Other items, net (40) (29)
Net cash provided by (used in) operating activities 1,430 1,123
Cash Flows from Investing Activities    
Additions to properties and equipment (1,547) (1,194)
Divestitures of properties and equipment and other assets 371 2,851
Other, net 63 66
Net cash provided by (used in) investing activities (1,113) 1,723
Cash Flows from Financing Activities    
Borrowings, net of issuance costs 1,333 0
Repayments of debt (639) (10)
Financing portion of net cash received (paid) for derivative instruments 54 (37)
Increase (decrease) in outstanding checks (26) 28
Dividends paid (127) (28)
Repurchases of common stock (1,959) (21)
Distributions to noncontrolling interest owners (118) (105)
Payments of future hard-minerals royalty revenues conveyed (25) (25)
Net cash provided by (used in) financing activities (1,507) (198)
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents 0 3
Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents (1,190) 2,651
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents at Beginning of Period 4,674 3,308
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents at End of Period $ 3,484 $ 5,959